Get this report today!
Summary
Table of Contents
Introduction
Global Spices & Stimulants industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the global spices & stimulants market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The spices and stimulants market consists of the spices group, which includes chillies, peppers, cloves, cinnamon, nutmeg, anise, ginger, vanilla and spices of domestic importance, whilst the stimulants segment includes coffee, cocoa, and tea. Both groups are accounted in unprocessed form and primary processed products. The market volumes reflect supply in each country, calculated on the basis of production plus imports minus exports. No allowance is made for changes in stock levels, and forage crops and wastage are also not included. Agricultural items are valued at producer prices. Any currency conversions included in this report have been calculated using constant 2010 annual average exchange rates.
*The global spices & stimulants industry had total revenue of $59.4 billion in 2010, representing a compound annual growth rate (CAGR) of 7.8% for the period spanning 2006-2010.
*Industry consumption volumes increased with a CAGR of 2.6% between 2006-2010, to reach a total of 45,554.6 thousand tons in 2010.
*The performance of the industry is forecast to decelerate, with an anticipated CAGR of 7.6% for the five-year period 2010-2015, which is expected to drive the industry to a value of $85.8 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the global spices & stimulants market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalspices & stimulants market
Leading company profiles reveal details of key spices & stimulants market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global spices & stimulants market with five year forecasts by both value and volume
Key Questions Answered
What was the size of the global spices & stimulants market by value in 2010?
What will be the size of the global spices & stimulants market in 2015?
What factors are affecting the strength of competition in the global spices & stimulants market?
How has the market performed over the last five years?
How has the market performed in volume terms over the last five years?
Get this report today!
Talk to Robyn
00 1 718 213 49 04
Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...
This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...
This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines and by the compound strategy of Peptides. Each of these three ...
... Use internally as part of a monthly cleansing regimen for gi health antibiotic, anti-inflammatory, antibacterial, antifungal, antioxidant, anti-parasitic, antiviral, disinfectant candida cleanse ...
... Antiosteoporosic drugs - casula m, filippi a, flacco e, gambera m, manzoli l, menditto e, orlando v, piccinelli r, tragni e, catapano a. Assessment and potential determinats of compliance and persistence to anti ...
... Clinical regulatory toxicology phase i clinical phase ii clinical diabetes inflammation oncology (non-cytotoxic) anti-infectives clotting disorders obesity cns nce pipeline nce pipeline tyrosine-tzd, non ...
Company Profiles
3 Companiesref:plp2011
Reportlinker.com © Copyright 2013. All rights reserved.